Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada

SUMMARY: We studied new users of oral bisphosphonates and found that less than half persisted with therapy for 2 years, and interruptions in use were common. During a median observation period of 4.7 years, 10% of patients filled only a single prescription, 37% switched therapies and median cumulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Burden, A. M., Paterson, J. M., Solomon, D. H., Mamdani, M., Juurlink, D. N., Cadarette, S. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277689/
https://www.ncbi.nlm.nih.gov/pubmed/21604008
http://dx.doi.org/10.1007/s00198-011-1645-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277689/
https://www.ncbi.nlm.nih.gov/pubmed/21604008
http://dx.doi.org/10.1007/s00198-011-1645-7

Ejemplares similares